BML Capital Management, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001616824

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHigh Turnover how tags are computed

Q3 2023 · 26 positions · Total reported value $108.90M · Top-10 concentration 89.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 38.1% · 3 new · 4 cut · 1 exited

Active Share (vs S&P 500): 99.2% · vs QQQ: 99.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +2.1% · vs SPY -0.0% · Prev Value $176.05M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -15.2% · vs SPY -17.3% · Latest Value $187.62M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, BML Capital Management, LLC disclosed 26 equity positions with a combined reported value of $108.90M. The filing implies a focused portfolio: its ten largest positions account for 89.6% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.

The largest disclosed positions as of Q3 2023 were SGOV ($27.18M), BIL ($18.36M), AVIR ($14.40M). By sector, the heaviest allocations are Health Care 25.1%, Industrials 2.0%.

Versus the prior quarter, BML Capital Management, LLC opened 3 new positions, trimmed 4 and fully exited 1, a turnover rate of 38.1% of positions.

The largest new positions opened in Q3 2023 were SGOV ($27.18M), BIL ($18.36M), AVIR ($14.40M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • SGOV ISHARES TR · $27.18M
  • BIL State Street SPDR Portfolio · $18.36M
  • AVIR ATEA PHARMACEUTICALS INC · $14.40M
  • CYTT CYTEIR THERAPEUTICS INC · $9.23M
  • AVRO AVROBIO INC · $6.16M
  • ADVM ADVERUM BIOTECHNOLOGIES INC · $5.87M
  • TALS TALARIS THERAPEUTICS INC · $5.62M
  • CLYM CLIMB BIO INC · $5.10M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest BML Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

BML Capital Management, LLC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 18 positions worth $176.05M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 18 positions · $176.05M reported value (Q2 2026)
  • Top 10 holdings = 93.3% of reported value
  • Largest position: ACRS (ACLARIS THERAPEUTICS INC) at 36.0%
  • Average position size: $9.78M

Sector Tilt

  • Health Care 80.1%
  • Consumer Discretionary 13.3%
  • Consumer Staples 6.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 3 new, 4 added, 3 reduced, 1 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 25.1%
Technology 0.1%
Other 72.8%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 270.00K $27.18M 24.96%
24.96%
New
2 200.00K $18.36M 16.86%
16.86%
New
3 4.80M $14.40M 13.22%
13.22%
New
4 3.25M $9.23M 8.48%
8.48%
New
5 4.00M $6.16M 5.66%
5.66%
New
6 3.92M $5.87M 5.39%
5.39%
New
7 2.00M $5.62M 5.16%
5.16%
New
8 1.94M $5.10M 4.68%
4.68%
New
9 1.70M $3.44M 3.16%
3.16%
New
10 220.41K $2.23M 2.04%
2.04%
New
11 781.29K $2.04M 1.87%
1.87%
New
12 706.93K $1.42M 1.30%
1.30%
New
13 2.06M $1.35M 1.24%
1.24%
New
14 1.76M $1.17M 1.07%
1.07%
New
15 272.50K $844.75K 0.78%
0.78%
New
16 50.00K $683.00K 0.63%
0.63%
New
17 499.96K $594.95K 0.55%
0.55%
New
18 150.00K $582.75K 0.54%
0.54%
New
19 100.00K $524.00K 0.48%
0.48%
New
20 243.84K $521.82K 0.48%
0.48%
New
21 108 $443.88K 0.41%
0.41%
New
22 306.46K $395.34K 0.36%
0.36%
New
23 98.66K $389.72K 0.36%
0.36%
New
24 88.78K $236.11K 0.22%
0.22%
New
25 72.93K $62.85K 0.06%
0.06%
New
26 89.27K $43.74K 0.04%
0.04%
New

FAQ

What did BML Capital Management, LLC buy in 2023-Q3?

In its 2023-Q3 13F filing, BML Capital Management, LLC reported 26 equity positions worth $108.90M in aggregate; its largest disclosed positions were SGOV ($27.18M), BIL ($18.36M), AVIR ($14.40M).

How large is BML Capital Management, LLC's portfolio?

BML Capital Management, LLC reported $108.90M of long equity holdings across 26 positions as of 2023-Q3. Top-10 holdings account for 89.6% of reported value.

What is BML Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bml-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →